Sagimet Biosciences (SGMT) Stock Chart & Stock Price History → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free SGMT Stock Alerts $4.44 +0.11 (+2.54%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Sagimet Biosciences Stock Price Performance5 Day Performance+2.78%1 Month Performance-17.47%3 Month Performance-26.00%6 Month Performance+26.50%Year-To-Date Performance-18.08% Receive SGMT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> SGMT Stock Chart for Wednesday, May, 8, 2024 SGMT Chart by TradingView Sagimet Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$4.33$4.44+2.54%$4.44$4.04312,812 shs$141.68 million05/07/2024$4.28$4.33+1.17%$4.40$4.16288,054 shs$138.17 million05/06/2024$4.32$4.28-0.93%$4.56$4.16559,221 shs$136.58 million05/03/2024$4.45$4.32-2.92%$4.76$4.25770,646 shs$137.85 million05/02/2024$4.11$4.45+8.27%$4.95$4.251.13 million shs$142 million05/01/2024$3.90$4.11+5.38%$4.28$3.94308,884 shs$131.15 million Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$4.23$3.90-7.80%$4.22$3.90598,993 shs$124.45 million04/29/2024$4.06$4.23+4.19%$4.29$4.05475,474 shs$135.00 million04/26/2024$3.92$4.06+3.57%$4.15$3.88325,271 shs$129.56 million04/25/2024$4.17$3.92-6.00%$4.08$3.91225,060 shs$125.10 million04/24/2024$4.28$4.17-2.57%$4.27$4.02219,072 shs$133.07 million04/23/2024$4.03$4.28+6.20%$4.31$4.01360,993 shs$136.58 million04/22/2024$4.01$4.03+0.50%$4.18$3.96303,611 shs$128.60 million04/19/2024$3.97$4.01+1.01%$4.07$3.83430,096 shs$127.96 million04/18/2024$4.07$3.97-2.46%$4.17$3.93337,339 shs$126.68 million04/17/2024$4.18$4.07-2.63%$4.36$4.05315,657 shs$129.87 million04/16/2024$4.56$4.18-8.33%$4.50$4.15430,611 shs$133.38 million04/15/2024$4.83$4.56-5.59%$4.88$4.50470,542 shs$145.53 million04/12/2024$5.22$4.83-7.47%$5.17$4.80433,715 shs$154.13 million04/11/2024$5.06$5.22+3.16%$5.30$4.95256,409 shs$166.59 million04/10/2024$5.31$5.06-4.71%$5.15$4.90488,800 shs$161.47 million04/09/2024$5.38$5.31-1.30%$5.53$5.02561,876 shs$169.44 million04/08/2024$5.31$5.38+1.32%$5.56$5.28472,117 shs$171.68 million04/05/2024$5.45$5.31-2.57%$5.50$5.29268,300 shs$169.44 million04/04/2024$5.43$5.45+0.37%$5.69$5.24748,389 shs$173.91 million04/03/2024$5.24$5.43+3.63%$5.55$5.11521,252 shs$173.27 million04/02/2024$5.23$5.24+0.19%$5.30$4.88585,542 shs$167.21 million04/01/2024$5.42$5.23-3.51%$5.83$5.21776,763 shs$111.79 million03/29/2024$5.42$5.42$6.05$5.351.15 million shs$115.88 million03/28/2024$5.73$5.42-5.41%$6.05$5.351.15 million shs$115.88 million03/27/2024$5.23$5.73+9.56%$6.06$5.001.26 million shs$122.51 million03/26/2024$5.22$5.23+0.19%$5.67$5.001.32 million shs$111.79 million03/25/2024$4.51$5.22+15.74%$5.70$4.753.24 million shs$111.60 million03/22/2024$4.65$4.51-3.01%$4.69$4.44474,614 shs$96.42 million03/21/2024$4.56$4.65+1.97%$4.98$4.51866,170 shs$99.39 million03/20/2024$4.48$4.56+1.79%$4.58$4.30453,453 shs$97.49 million03/19/2024$4.02$4.48+11.44%$4.72$4.031.44 million shs$95.78 million03/18/2024$4.04$4.02-0.50%$4.24$3.85637,037 shs$85.95 million03/15/2024$4.32$4.04-6.48%$4.58$3.973.86 million shs$86.38 million03/14/2024$4.65$4.32-7.10%$4.73$4.261.79 million shs$92.36 millionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/13/2024$4.99$4.65-6.81%$5.26$4.521.31 million shs$99.42 million03/12/2024$5.48$4.99-8.94%$5.57$4.971.04 million shs$106.66 million03/11/2024$5.75$5.48-4.70%$5.94$5.46491,429 shs$117.16 million03/08/2024$6.45$5.75-10.85%$6.76$5.75595,974 shs$122.94 million03/07/2024$6.67$6.45-3.30%$7.41$6.35775,732 shs$137.87 million03/06/2024$6.05$6.67+10.25%$6.70$6.07602,738 shs$142.61 million03/05/2024$6.25$6.05-3.20%$6.34$5.61696,238 shs$129.35 million03/04/2024$6.02$6.25+3.82%$6.45$5.75830,932 shs$133.63 million03/01/2024$6.13$6.02-1.79%$6.65$5.85742,817 shs$128.71 million02/29/2024$6.39$6.13-4.07%$6.83$5.90796,034 shs$131.06 million02/28/2024$7.39$6.39-13.53%$7.36$6.39729,202 shs$136.62 million02/27/2024$7.20$7.39+2.64%$7.64$7.03766,502 shs$157.96 million02/26/2024$6.62$7.20+8.76%$7.26$6.59665,193 shs$153.94 million02/23/2024$6.73$6.62-1.63%$7.10$6.51631,428 shs$141.54 million02/22/2024$6.74$6.73-0.15%$7.38$6.47894,031 shs$143.85 million02/21/2024$6.98$6.74-3.44%$7.26$6.67678,429 shs$144.10 million02/20/2024$7.55$6.98-7.55%$8.07$6.981.15 million shs$149.23 million02/19/2024$7.55$7.55$8.58$7.501.28 million shs$161.42 million02/16/2024$8.66$7.55-12.82%$8.58$7.501.28 million shs$161.42 million02/15/2024$8.09$8.66+7.05%$8.75$7.931.11 million shs$185.15 million02/14/2024$7.42$8.09+9.03%$8.59$7.201.47 million shs$172.96 million02/13/2024$8.01$7.42-7.37%$7.69$6.801.06 million shs$158.64 million02/12/2024$6.24$8.01+28.37%$8.15$6.382.41 million shs$171.21 million02/09/2024$6.00$6.24+4.00%$6.60$5.601.55 million shs$133.41 million02/08/2024$6.58$6.00-8.81%$6.84$5.851.62 million shs$128.28 million02/07/2024$6.35$6.58+3.62%$6.60$5.961.81 million shs$140.68 million Related Companies: Karyopharm Therapeutics Stock Chart Vistagen Therapeutics Stock Chart Coya Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart InterCure Stock Chart PDS Biotechnology Stock Chart Citius Pharmaceuticals Stock Chart Repare Therapeutics Stock Chart Societal CDMO Stock Chart Nuvectis Pharma Stock Chart Receive SGMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SGMT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.